- First-in-class antigen-specific immunotherapy for multiple sclerosis
- Designed to restore immune homeostasis
- Single-administration, liver-directed immunotherapy for durable immune tolerance
- Minimized risk associated with broad immunosuppression
- In vivo therapeutic effect video available upon specific request (meeting with Hera Lichenbeld)